- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01848938
Treatment of Stress Urinary Incontinence Via Smartphone
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Female urinary incontinence (UI) is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or jumping.
The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to improvement or cure in two-thirds of patients. In addition, life style changes, such as weight loss when obese, smoking cessation and reduction of fluid intake if high is recommended.
There is a need for new , flexible and easily accessible treatment programmes for female urinary incontinence. In our previous study, we compared two treatment programmes for SUI without face-to-face contact: one internet based and one sent by post, both based on three months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found highly significant improvements (p<0.001) with large effect sizes (>0,8)concerning primary outcomes (symptoms and quality of life scores) but no significant differences between groups. Compared with the postal group, more participants in the internet group perceived they were much or very much improved (40.9% vs 26.5%, p<0.01, reported reduced usage of incontinence aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs 62.9%, p<0.001).
The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular types.
From our previous experience of an Internet-based programme, we have developed a treatment program designed for smartphone. The effect of the treatment programme will be evaluated after three months by comparing the effect in the "smartphone group" with the effect in the "waiting group".
Participants are consecutively recruited through our website. They answer an online screening survey with automated immediated response for initial screening of eligibility criteria. Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours) are sent by post. After that, they answer a web questionnaire and finally they are interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is well informed of the study procedure.
Women are then randomized to either of the two groups. Women in the smartphone group get a smartphone application for iphone or android. Follow-up after three months with a web questionnaire and a leakage diary. After that the waiting group get their smartphone application.
We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in the postal group in our previous study. We also assume that the waiting group will improve in some extent.
To detect a difference between groups, power 80%, 2-side test and significance 0,05, group size as follow
ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each group
ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each group
PGI (patient´s global impression of improvement). 26,5% improves much or very much (smartphone) and 4% (waiting group):39 in each group
We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Umeå, Suède, S-90185
- Umeå University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- stress urinary incontinence
- leakage once a week or more often
- duration of symptoms for at least 6 months
- motivation and time to perform a 12 week long treatment with pelvic floor muscle training
- ability to read and write Swedish
- asset to smartphone
- possibility to send and receive email and asset to printer
- accept to be randomized to one of two groups; a treatment group or a waiting list group
Exclusion Criteria:
- participation in our previous internet study
- pregnancy
- former incontinence surgery
- known malignancy in lower abdomen
- difficulties with passing urine
- visual blood in urine
- intermenstrual bleeding
- severe psychiatric diagnosis
- neurological disease with affection on sensibility in legs or lower abdomen
- urge incontinence
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Smartphone treatment
Smartphone treatment with PFMT.
|
A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training.
The treatment period is three months
|
|
Aucune intervention: Waiting list
Waiting list for three months.
They receive the smartphone application after follow-up.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Délai: baseline, three months
|
Three items on frequency, amount of leakage and overall impact.
Scoring 0-21, higher values indicating increasing severity
|
baseline, three months
|
|
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
Délai: baseline, three months
|
The instrument includes 19 items on the impact of the leakage.
All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time).
The overall score is 19-76, with higher values indicating increased impact on QOL.
|
baseline, three months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Usage of Incontinence Aids
Délai: three months
|
Usage of incontinence aids during the last 4 weeks.
|
three months
|
|
Patient Satisfaction
Délai: three months
|
A self-rated question about if the current treatment was sufficient, with three response options
|
three months
|
|
Incontinence Episode Frequency (IEF)
Délai: baseline, three months
|
number of incontinence episodes per week
|
baseline, three months
|
|
Patient's Global Impression of Improvement Scale (PGI-I)
Délai: three months
|
A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from "very much better" to "very much worse".
|
three months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Eva Samuelsson, MD, PhD, Department of Public Health and Clinical Medicine, Umeå University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- VisareNorr301811
- JLL314561 (Autre subvention/numéro de financement: The County council of Jämtland)
- FAS2008-0952 (Autre subvention/numéro de financement: Swedish Council for Working Life and Social research)
- ALFVLL222081 (Autre subvention/numéro de financement: Västerbotten County Council (ALF))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .